Yahoo Finance

BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations

PARIS, May 06, 2025--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today the 510(k) clearance for updates ...
GlobalData on MSN

BrightHeart’s AI demonstrates promise in congenital heart defect detection

BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new ...
Morningstar

BrightHeart Sets New Standard in Prenatal CHD Screening with Landmark Study Published in Obstetrics & Gynecology

BrightHeart, a pioneer in AI-driven prenatal ultrasound evaluation, today announced the publication of its landmark study in Obstetrics & Gynecology, commonly known as the Green Journal. The study, ...
Morningstar

BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care

BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on ...